The biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide. This N-terminal sequence is identical in several mammalian species, such as human, pig, and cattle. It is used to diagnose or treat patients with GROWTH HORMONE deficiency.
Sermorelin has been studied across 5 research domains including 🧬 Hormones, 🧠 Focus & Attention, 💪 Strength & Power, ⏳ Longevity & Aging, ✨ Skin & Hair. The primary research focus is 🧬 Hormones with 70% of studies addressing this area.
This evidence profile for Sermorelin is generated deterministically from 20 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.